• 1. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 2. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 3. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 4. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

Introduction to 1,3,2-Dioxaborolane, 2-(2-bromo-4-chlorophenyl)-4,4,5,5-tetramethyl- (CAS No. 1256781-67-5)

The compound 1,3,2-Dioxaborolane, 2-(2-bromo-4-chlorophenyl)-4,4,5,5-tetramethyl- (CAS No. 1256781-67-5) represents a significant advancement in the field of organoboron chemistry, particularly in the context of pharmaceutical and materials science applications. This borylated heterocyclic structure combines the versatility of boron-containing intermediates with a highly functionalized aromatic system, making it a valuable reagent in synthetic chemistry. The presence of both bromo and chloro substituents on the phenyl ring enhances its reactivity, enabling diverse transformations such as cross-coupling reactions and nucleophilic substitutions.

In recent years, boron-containing compounds have garnered considerable attention due to their unique electronic properties and biological activities. Among these, 1,3,2-Dioxaborolane derivatives have been extensively studied for their role in Suzuki-Miyaura cross-coupling reactions, which are pivotal in constructing complex organic molecules. The specific substitution pattern in 2-(2-bromo-4-chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane not only facilitates efficient coupling with various aryl halides but also introduces steric and electronic tuning through the tetramethyl group at the boron center. This modification enhances stability while maintaining high reactivity.

The tetramethyl-substituted dioxaborolane core is particularly noteworthy for its improved handling characteristics compared to unsubstituted analogs. The methyl groups not only shield the boron center from unwanted side reactions but also influence the electronic environment of the boron-boron bond. This makes the compound exceptionally useful in large-scale syntheses where robustness and reproducibility are critical. Furthermore, the bromo and chloro phenyl ring serves as an excellent handle for further functionalization via palladium-catalyzed reactions or direct lithiation protocols.

Recent advancements in drug discovery have highlighted the importance of boron-containing pharmaceuticals, such as borylated kinase inhibitors and radiopharmaceuticals for PET imaging. The compound under discussion (CAS No. 1256781-67-5) aligns well with this trend by providing a versatile scaffold for developing novel therapeutic agents. For instance, researchers have leveraged similar dioxaborolane derivatives to synthesize potent inhibitors of targets implicated in oncology and neurodegenerative diseases. The aromatic system's ability to engage in π-stacking interactions with biological macromolecules further expands its potential applications in medicinal chemistry.

The synthesis of 1,3,2-Dioxaborolane derivatives typically involves multi-step procedures starting from readily available precursors such as ketones or aldehydes. The introduction of bromo and chloro substituents can be achieved through halogenation protocols using reagents like N-bromosuccinimide (NBS) or phosphorus oxychloride (POCl?). Subsequent formation of the dioxaborolane ring requires a borylation step using bis(pinacolato)diboron or other organoboron reagents under palladium catalysis. The final product is then purified via column chromatography or recrystallization to afford high-purity material suitable for downstream applications.

In materials science applications, tetramethyl-substituted dioxaborolanes exhibit interesting properties due to their ability to act as precursors for polymerization or as crosslinking agents in epoxy resins. The boron center's coordination chemistry allows it to form stable complexes with metal catalysts used in polymerization reactions. Additionally, 2-(2-bromo-4-chlorophenyl)- substituents can impart flame-retardant characteristics when incorporated into polymeric matrices by enhancing char formation during combustion.

From an industrial perspective, CAS No. 1256781-67-5 represents a high-value intermediate that bridges academic research with commercial production needs. Its stability under storage conditions makes it ideal for large-scale inventory stocking without degradation concerns over extended periods. Moreover, its compatibility with green chemistry principles, such as reduced reliance on hazardous solvents through catalytic methods, underscores its sustainability credentials.

The future directions for research involving this compound include exploring novel catalytic systems that enhance reaction efficiency while minimizing waste generation. Additionally, computational studies could provide deeper insights into how steric and electronic factors influence reaction outcomes, guiding rational molecular design efforts moving forward.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)